133 related articles for article (PubMed ID: 11295097)
1. Inverse association of non-steroidal anti-inflammatory drugs and malignant melanoma among women.
Harris RE; Beebe-Donk J; Namboodiri KK
Oncol Rep; 2001; 8(3):655-7. PubMed ID: 11295097
[TBL] [Abstract][Full Text] [Related]
2. Non-steroidal anti-inflammatory drugs, acetaminophen, and risk of skin cancer in the Nurses' Health Study.
Jeter JM; Han J; Martinez ME; Alberts DS; Qureshi AA; Feskanich D
Cancer Causes Control; 2012 Sep; 23(9):1451-61. PubMed ID: 22763500
[TBL] [Abstract][Full Text] [Related]
3. Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.
Marshall SF; Bernstein L; Anton-Culver H; Deapen D; Horn-Ross PL; Mohrenweiser H; Peel D; Pinder R; Purdie DM; Reynolds P; Stram D; West D; Wright WE; Ziogas A; Ross RK
J Natl Cancer Inst; 2005 Jun; 97(11):805-12. PubMed ID: 15928301
[TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal anti-inflammatory drugs and the risk of nonmelanoma skin cancer.
Reinau D; Surber C; Jick SS; Meier CR
Int J Cancer; 2015 Jul; 137(1):144-53. PubMed ID: 25418602
[TBL] [Abstract][Full Text] [Related]
5. Aspirin and other NSAIDs as chemoprevention agents in melanoma.
Goodman JR; Grossman D
Cancer Prev Res (Phila); 2014 Jun; 7(6):557-64. PubMed ID: 24694780
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative.
Harris RE; Chlebowski RT; Jackson RD; Frid DJ; Ascenseo JL; Anderson G; Loar A; Rodabough RJ; White E; McTiernan A;
Cancer Res; 2003 Sep; 63(18):6096-101. PubMed ID: 14522941
[TBL] [Abstract][Full Text] [Related]
7. Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: the Women's Health Initiative.
Gamba CA; Swetter SM; Stefanick ML; Kubo J; Desai M; Spaunhurst KM; Sinha AA; Asgari MM; Sturgeon S; Tang JY
Cancer; 2013 Apr; 119(8):1562-9. PubMed ID: 23483536
[TBL] [Abstract][Full Text] [Related]
8. Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk.
Terry MB; Gammon MD; Zhang FF; Tawfik H; Teitelbaum SL; Britton JA; Subbaramaiah K; Dannenberg AJ; Neugut AI
JAMA; 2004 May; 291(20):2433-40. PubMed ID: 15161893
[TBL] [Abstract][Full Text] [Related]
9. A large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence.
Asgari MM; Maruti SS; White E
J Natl Cancer Inst; 2008 Jul; 100(13):967-71. PubMed ID: 18577752
[TBL] [Abstract][Full Text] [Related]
10. Nonsteroidal anti-inflammatory drugs and the risk of skin cancer: a population-based case-control study.
Johannesdottir SA; Chang ET; Mehnert F; Schmidt M; Olesen AB; Sørensen HT
Cancer; 2012 Oct; 118(19):4768-76. PubMed ID: 22644960
[TBL] [Abstract][Full Text] [Related]
11. Non-steroidal anti-inflammatory drugs and melanoma risk: large Dutch population-based case-control study.
Joosse A; Koomen ER; Casparie MK; Herings RM; Guchelaar HJ; Nijsten T
J Invest Dermatol; 2009 Nov; 129(11):2620-7. PubMed ID: 19587697
[TBL] [Abstract][Full Text] [Related]
12. Non-steroidal anti-inflammatory drugs and cancer risk in women: results from the Women's Health Initiative.
Brasky TM; Liu J; White E; Peters U; Potter JD; Walter RB; Baik CS; Lane DS; Manson JE; Vitolins MZ; Allison MA; Tang JY; Wactawski-Wende J
Int J Cancer; 2014 Oct; 135(8):1869-83. PubMed ID: 24599876
[TBL] [Abstract][Full Text] [Related]
13. Non-steroidal anti-inflammatory drug use and colorectal polyps in the Prostate, Lung, Colorectal, And Ovarian Cancer Screening Trial.
Johnson CC; Hayes RB; Schoen RE; Gunter MJ; Huang WY;
Am J Gastroenterol; 2010 Dec; 105(12):2646-55. PubMed ID: 20808298
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis.
Takkouche B; Regueira-Méndez C; Etminan M
J Natl Cancer Inst; 2008 Oct; 100(20):1439-47. PubMed ID: 18840819
[TBL] [Abstract][Full Text] [Related]
15. Non-steroidal anti-inflammatory drugs and the risk of head and neck cancer: A case-control analysis.
Becker C; Wilson JC; Jick SS; Meier CR
Int J Cancer; 2015 Nov; 137(10):2424-31. PubMed ID: 25974157
[TBL] [Abstract][Full Text] [Related]
16. Aspirin as a chemopreventive agent for cutaneous melanoma: a literature review.
Pulumati A; Algarin YA; Jaalouk D; Kim S; Latta S; Nouri K
Arch Dermatol Res; 2024 Jun; 316(7):367. PubMed ID: 38850411
[TBL] [Abstract][Full Text] [Related]
17. Aspirin may lower melanoma risk.
Harv Womens Health Watch; 2013 Jun; 20(10):8. PubMed ID: 23977710
[No Abstract] [Full Text] [Related]
18. Aspirin use and melanoma: A UCLA pilot study.
Famenini S; Duan L; Young L
J Am Acad Dermatol; 2015 Jun; 72(6):1094-5. PubMed ID: 25981013
[No Abstract] [Full Text] [Related]
19. Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokers.
Harris RE; Beebe-Donk J; Schuller HM
Oncol Rep; 2002; 9(4):693-5. PubMed ID: 12066194
[TBL] [Abstract][Full Text] [Related]
20. Long-term use of nonsteroidal anti-inflammatory drugs decreases the risk of cutaneous melanoma: results of a United States case-control study.
Curiel-Lewandrowski C; Nijsten T; Gomez ML; Hollestein LM; Atkins MB; Stern RS
J Invest Dermatol; 2011 Jul; 131(7):1460-8. PubMed ID: 21390049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
